SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-027120
Filing Date
2024-07-12
Accepted
2024-07-12 17:00:40
Documents
13
Period of Report
2024-07-12
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 57653
  Complete submission text file 0001493152-24-027120.txt   237500

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE mira-20240712.xsd EX-101.SCH 3048
3 XBRL LABEL FILE mira-20240712_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE mira-20240712_pre.xml EX-101.PRE 22381
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3817
Mailing Address 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606
Business Address 1200 BRICKELL AVENUE SUITE 1950 #1183 MIAMI FL 33131 813-369-5150
MIRA PHARMACEUTICALS, INC. (Filer) CIK: 0001904286 (see all company filings)

IRS No.: 853354547 | State of Incorp.: FL
Type: 8-K | Act: 34 | File No.: 001-41765 | Film No.: 241115128
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)